EUVIMEDEUVIMED entdecken
Crossref

HRCT Chest in ILD with Pulmonary Function Test Correlation

Dr Akanksha, Dr Sohan Singh, Dr Amit Jain

International Journal of Drug Delivery Technology · 30.05.2026 · 16 (38s)

DOI: 10.25258/ijddt.16.38s.86 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.05.2026. Verfasst von Dr Akanksha und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interstitial lung diseases (ILDs) are a heterogeneous group of diffuse parenchymal lung disorders characterized by inflammation and fibrosis, leading to progressive respiratory impairment. High-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) are essential tools for diagnosis and assessment of disease severity.

Aim

To evaluate HRCT chest findings in ILD patients and correlate them with pulmonary function test parameters. Materials and Methods: This hospital-based observational study was conducted in the Department of Radiodiagnosis at Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, Haryana, over a period of one year. A total of 100 patients with suspected or diagnosed Interstitial Lung Disease (ILD) were included. All patients underwent High-Resolution Computed Tomography (HRCT) of the chest and Pulmonary Function Testing (PFT), including measurement of Forced Vital Capacity (FVC) and Diffusing Capacity of the Lung for Carbon Monoxide (DLCO). HRCT patterns and disease severity were analyzed and correlated with PFT parameters. The HRCT examinations were performed using a Philips Ingenuity 128-slice Computed Tomography scanner.

Results

The majority of patients were in the 51–60 years age group (32%) with male predominance (58%). Honeycombing (30%) and ground-glass opacities (28%) were the most common HRCT findings. Moderate disease severity was observed in 46% of patients. Pulmonary function tests showed predominantly restrictive patterns, with 38% having moderate reduction in FVC. DLCO was moderately reduced in 40% of patients. A statistically significant correlation was found between HRCT severity and PFT parameters (p < 0.05).

Conclusion

HRCT is a reliable tool for diagnosing and assessing ILD severity and shows strong correlation with pulmonary function impairment. Combined evaluation using HRCT and PFTs enhances diagnostic accuracy and aids in better management and prognostication.

Zitieren

APA

Akanksha, D., Singh, D. S., & Jain, D. A. (2026). HRCT Chest in ILD with Pulmonary Function Test Correlation. International Journal of Drug Delivery Technology, 16(38s). https://doi.org/10.25258/ijddt.16.38s.86

Vancouver

Akanksha D, Singh DS, Jain DA. HRCT Chest in ILD with Pulmonary Function Test Correlation. International Journal of Drug Delivery Technology. 2026;16(38s). doi:10.25258/ijddt.16.38s.86

BibTeX
@article{Akanksha2026,
  author = {Akanksha, Dr and Singh, Dr Sohan and Jain, Dr Amit},
  title = {HRCT Chest in ILD with Pulmonary Function Test Correlation},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {38s},
  doi = {10.25258/ijddt.16.38s.86}
}
Kostenlos starten →